22 August 2013. Moscow, Russia.The Medsi Group of Companies and its subsidiaries ("Medsi" or "the Group"), a leading national provider of medical and healthcare services in Moscow and other regions of Russia, has today published its unaudited consolidated US GAAP financial results for the six months to 30 June 2013.

MAIN FINANCIAL RESULTS

- Revenues totaled US$147.2 million, up 53.8% year-on-year, as Medsi completed the consolidation of the Medical Center for the Mayor and Government of Moscow (MCMGM), and the average ticket and patient numbers rose

- Driven by the increase in revenues, OIBDA equaled US$15.2 million, up 39.3% year-on-year, while the OBIDA margin came to 10.3%

- The ratio of sales, general and administrative expenses (SG&A) to revenues was 14.1%, down from 15.0% in 1H12

- The average ticket was US$47.7, up 9.9% year-on-year

- Net profit stood at US$0.4 million, compared with a net loss of US$3.4 million in in 1H12.

- Net debt stood at US$42.7 million as of 30 June 2013, down2317.19% from 31 December 2012

- The number of visits equaled 2.918 million, up 32.2% year-on-year

Commenting on the results, Medsi President Alexey Chupin said:

"In the first half of 2013, Medsi completed the consolidation of MCMGM and, as planned, continued integrating its assets, a process that we expect to finish fully by the end of this year.

The Group also devoted a lot of effort to making its medical services more efficient. Notably, together with leading international experts, we conducted a comprehensive evaluation of all of our services, prepared a detailed development plan, and integrated our in-patient, outpatient and respite care segments in line with international best practices.

This comprehensive approach allowed us to continue phasing in our "patient-oriented" model of medical care and transforming Medsi into a provider of the full range of medical services, from clinics to hospitals and sanatoria."